17-81809071-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_000160.5(GCGR):​c.53C>A​(p.Ala18Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000586 in 1,535,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000051 ( 0 hom. )

Consequence

GCGR
NM_000160.5 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.360
Variant links:
Genes affected
GCGR (HGNC:4192): (glucagon receptor) The protein encoded by this gene is a glucagon receptor that is important in controlling blood glucose levels. Defects in this gene are a cause of non-insulin-dependent diabetes mellitus (NIDDM).[provided by RefSeq, Jan 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.09195301).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GCGRNM_000160.5 linkuse as main transcriptc.53C>A p.Ala18Asp missense_variant 2/14 ENST00000400723.8 NP_000151.1 P47871
GCGRXM_006722277.2 linkuse as main transcriptc.53C>A p.Ala18Asp missense_variant 2/14 XP_006722340.1 P47871
GCGRXM_017024446.2 linkuse as main transcriptc.53C>A p.Ala18Asp missense_variant 2/14 XP_016879935.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GCGRENST00000400723.8 linkuse as main transcriptc.53C>A p.Ala18Asp missense_variant 2/141 NM_000160.5 ENSP00000383558.3 P47871
GCGRENST00000572185.1 linkuse as main transcriptn.348C>A non_coding_transcript_exon_variant 2/31
GCGRENST00000570996.5 linkuse as main transcriptc.53C>A p.Ala18Asp missense_variant 2/122 ENSP00000460976.1 I3L454
GCGRENST00000573428.1 linkuse as main transcriptc.53C>A p.Ala18Asp missense_variant 2/44 ENSP00000458930.1 I3L1L8

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152242
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000725
AC:
1
AN:
137886
Hom.:
0
AF XY:
0.0000135
AC XY:
1
AN XY:
73866
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000408
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000506
AC:
7
AN:
1383648
Hom.:
0
Cov.:
32
AF XY:
0.00000732
AC XY:
5
AN XY:
682708
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000280
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000560
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.27e-7
Gnomad4 OTH exome
AF:
0.0000518
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152242
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74376
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000385
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 25, 2022The c.53C>A (p.A18D) alteration is located in exon 2 (coding exon 1) of the GCGR gene. This alteration results from a C to A substitution at nucleotide position 53, causing the alanine (A) at amino acid position 18 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
4.6
DANN
Benign
0.67
DEOGEN2
Benign
0.15
T;.;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.054
N
LIST_S2
Benign
0.40
T;T;T
M_CAP
Uncertain
0.095
D
MetaRNN
Benign
0.092
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.5
L;.;.
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-1.1
N;.;.
REVEL
Benign
0.034
Sift
Benign
0.11
T;.;.
Sift4G
Benign
0.53
T;D;T
Polyphen
0.089
B;.;.
Vest4
0.19
MutPred
0.55
Gain of relative solvent accessibility (P = 0.0479);Gain of relative solvent accessibility (P = 0.0479);Gain of relative solvent accessibility (P = 0.0479);
MVP
0.54
MPC
0.0023
ClinPred
0.051
T
GERP RS
-1.9
Varity_R
0.14
gMVP
0.52

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1335228562; hg19: chr17-79766947; API